Inhibition of Rev-erbα ameliorates muscular dystrophy
- 1. Department of Diabetes Complications & Metabolism, Beckman Research Institute of City of Hope, Duarte, CA, 91010 (United States)
- 2. Diabetes and Beta Cell Biology Center, Division of Endocrinology, Diabetes & Metabolism, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, 15261 (United States)
Description
Highlights: • Rev-erbα ablation in mdx mice protects against muscle damage and wasting. • Loss of Rev-erbα promoted regenerative myogenesis in mdx mice. • Rev-erbα deficiency in dystrophic muscle reduced inflammatory response. • Loss of Rev-erbα in mdx primary myoblasts promoted proliferation and differentiation. Duchene muscular dystrophy leads to progressive muscle structural and functional decline due to chronic degenerative-regenerative cycles. Enhancing the regenerative capacity of dystrophic muscle provides potential therapeutic options. We previously demonstrated that the circadian clock repressor Rev-erbα inhibited myogenesis and Rev-erbα ablation enhanced muscle regeneration. Here we show that Rev-erbα deficiency in the dystrophin-deficient mdx mice promotes regenerative myogenic response to ameliorate muscle damage. Loss of Rev-erbα in mdx mice improved dystrophic pathology and muscle wasting. Rev-erbα-deficient dystrophic muscle exhibit augmented myogenic response, enhanced neo-myofiber formation and attenuated inflammatory response. In mdx myoblasts devoid of Rev-erbα, myogenic differentiation was augmented together with up-regulation of Wnt signaling and proliferative pathways, suggesting that loss of Rev-erbα inhibition of these processes contributed to the improvement in regenerative myogenesis. Collectively, our findings revealed that the loss of Rev-erbα function protects dystrophic muscle from injury by promoting myogenic repair, and inhibition of its activity may have therapeutic utilities for muscular dystrophy.
Availability note (English)
Available from http://dx.doi.org/10.1016/j.yexcr.2021.112766Additional details
Identifiers
- DOI
- 10.1016/j.yexcr.2021.112766;
- PII
- S0014482721003190;
Publishing Information
- Journal Title
- Experimental Cell Research
- Journal Volume
- 406
- Journal Issue
- 2
- Journal Page Range
- vp.
- ISSN
- 0014-4827
- CODEN
- ECREAL
INIS
- Country of Publication
- United States
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 53119137
- Subject category
- S60: APPLIED LIFE SCIENCES;
- Descriptors DEI
- ABLATION; BIOLOGICAL REPAIR; CELL PROLIFERATION; INFLAMMATION; INHIBITION; INJURIES; MICE; MYOBLASTS; REGENERATION
- Descriptors DEC
- ANIMALS; BIOLOGICAL RECOVERY; DISEASES; MAMMALS; MUSCLES; PATHOLOGICAL CHANGES; REPAIR; RODENTS; SYMPTOMS; VERTEBRATES
Optional Information
- Copyright
- Copyright (c) 2021 Elsevier Inc. All rights reserved.